オハイオにおける重症筋無力症の臨床試験
オハイオ内の拠点で、重症筋無力症に関する13件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10103, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07463521ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- University of Cincinnati Medical Center - Goodman St, Cincinnati
- Ohio State Martha Morehouse Outpatient Care, Columbus
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT07294170A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0039 10103, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07465289ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- University of Cincinnati Medical Center - Goodman St, Cincinnati
- Ohio State Martha Morehouse Outpatient Care, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07284420Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Miami Valley Hospital South, Centerville
- University of Cincinnati, Cincinnati
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT06463587A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06680037Zilucoplan for Severe gMG Exacerbations
- The Ohio State University, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07215949Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- The Ohio State University, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06414954Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1038, Cincinnati
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/07/30更新 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Cleveland Clinic, Cleveland
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/27更新 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of Cincinnati Health Physicians - Clifton, Cincinnati
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/18更新 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Ohio State University, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/25更新 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Dayton
被験者募集中観察研究
18歳以上 · 全性別 · 2026/02/18更新 · NCT04202341ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。